<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Myeloid and plasmacytoid dendritic cells (MDCs, PDCs) play a key role in the initiation of immune responses </plain></SENT>
<SENT sid="1" pm="."><plain>In this study, we show a severe reduction of MDCs and PDCs in patients with B lineage <z:hpo ids='HP_0011009'>acute</z:hpo> lymphoblastic <z:mpath ids='MPATH_336'>leukaemia</z:mpath> (<z:e sem="disease" ids="C0023435" disease_type="Neoplastic Process" abbrv="">B-ALL</z:e>; P = 0.01 vs. controls) </plain></SENT>
<SENT sid="2" pm="."><plain>DCs from patients with T lineage ALL (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">T-ALL</z:e>) were quantitatively and functionally comparable to healthy donors, as demonstrated by secretion of interleukin (IL)-12p70 and interferon-alpha </plain></SENT>
<SENT sid="3" pm="."><plain>In vitro, the circulating CD34(+) fraction of <z:e sem="disease" ids="C0023435" disease_type="Neoplastic Process" abbrv="">B-ALL</z:e> cases did not generate either CD1a(+) MDCs or PDCs, suggesting that DC development is probably affected in <z:e sem="disease" ids="C0023435" disease_type="Neoplastic Process" abbrv="">B-ALL</z:e>, but not in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">T-ALL</z:e> </plain></SENT>
</text></document>